دورية أكاديمية

Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice.

التفاصيل البيبلوغرافية
العنوان: Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice.
المؤلفون: Zaw AM; School of Biological Sciences, The University of Hong Kong, Hong Kong, China., Sekar R; School of Biological Sciences, The University of Hong Kong, Hong Kong, China., Mak SOK; School of Biological Sciences, The University of Hong Kong, Hong Kong, China., Law HKW; Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong, China. helen.law@polyu.edu.hk., Chow BKC; School of Biological Sciences, The University of Hong Kong, Hong Kong, China. bkcc@hku.hk.
المصدر: Scientific reports [Sci Rep] 2019 Oct 02; Vol. 9 (1), pp. 14211. Date of Electronic Publication: 2019 Oct 02.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Blood Pressure/*physiology , Hypertension/*physiopathology , Hypertension, Pulmonary/*physiopathology , Lung/*pathology , Myocardium/*pathology , Secretin/*deficiency, Airway Remodeling ; Aldosterone/analysis ; Angiotensin II/blood ; Animals ; Hemodynamics ; Hypertension/blood ; Hypertension/genetics ; Hypertension, Pulmonary/blood ; Hypertension, Pulmonary/genetics ; Lung/chemistry ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Myocardium/chemistry ; Nitric Oxide/blood ; Renin/blood ; Secretin/genetics ; Telemetry ; Vascular Endothelial Growth Factor A/analysis ; Vasopressins/blood
مستخلص: More than 1 billion people globally are suffering from hypertension, which is a long-term incurable medical condition that can further lead to dangerous complications and death if left untreated. In earlier studies, the brain-gut peptide secretin (SCT) was found to be able to control blood pressure by its cardiovascular and pulmonary effects. For example, serum SCT in patients with congestive heart failure was one-third of the normal level. These observations strongly suggest that SCT has a causal role in blood pressure control, and in this report, we used constitutive SCT knockout (SCT -/- ) mice and control C57BL/6N mice to investigate differences in the morphology, function, underlying mechanisms and response to SCT treatment. We found that SCT -/- mice suffer from systemic and pulmonary hypertension with increased fibrosis in the lungs and heart. Small airway remodelling and pulmonary inflammation were also found in SCT -/- mice. Serum NO and VEGF levels were reduced and plasma aldosterone levels were increased in SCT -/- mice. Elevated cardiac aldosterone and decreased VEGF in the lungs were observed in the SCT -/- mice. More interestingly, SCT replacement in SCT -/- mice could prevent the development of heart and lung pathologies compared to the untreated group. Taken together, we comprehensively demonstrated the critical role of SCT in the cardiovascular and pulmonary systems and provide new insight into the potential role of SCT in the pathological development of cardiopulmonary and cardiovascular diseases.
References: Circulation. 2012 Aug 21;126(8):963-74. (PMID: 22787113)
Pulm Circ. 2012 Oct;2(4):434-42. (PMID: 23372927)
J Clin Invest. 2005 Oct;115(10):2811-21. (PMID: 16200212)
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13176-81. (PMID: 8917564)
Nat Protoc. 2014 Jul;9(7):1662-81. (PMID: 24945383)
Nat Med. 2003 Jun;9(6):669-76. (PMID: 12778165)
Cardiovasc Res. 2013 Nov 1;100(2):211-21. (PMID: 23863197)
Lancet. 2017 Jan 7;389(10064):37-55. (PMID: 27863813)
J Am Coll Cardiol. 2003 Feb 19;41(4):666-73. (PMID: 12598081)
Am J Respir Cell Mol Biol. 1993 Oct;9(4):429-33. (PMID: 8398181)
Hypertension. 2005 Apr;45(4):766-72. (PMID: 15699471)
Pediatr Res. 2006 Mar;59(3):412-7. (PMID: 16492981)
FASEB J. 2009 Jul;23(7):2176-85. (PMID: 19255254)
J Appl Physiol (1985). 2002 Dec;93(6):2162-70. (PMID: 12391106)
J Vis Exp. 2011 Jun 07;(52):. (PMID: 21673649)
Cardiovasc Res. 1997 Jul;35(1):138-47. (PMID: 9302358)
J Clin Invest. 2003 Apr;111(7):1083-92. (PMID: 12671058)
J Lipid Res. 2014 Feb;55(2):190-200. (PMID: 24273196)
Circ Res. 2011 Sep 30;109(8):867-79. (PMID: 21868697)
J Am Coll Cardiol. 2004 Dec 21;44(12):2390-7. (PMID: 15607403)
Circulation. 2007 Mar 13;115(10):1260-8. (PMID: 17309917)
Heart. 2003 Feb;89(2):207-8. (PMID: 12527680)
Nat Rev Nephrol. 2013 Aug;9(8):459-69. (PMID: 23774812)
Exp Physiol. 2013 May;98(5):973-87. (PMID: 23243148)
Am J Respir Crit Care Med. 2012 Oct 15;186(8):790-6. (PMID: 22798320)
Crit Care Med. 2005 Apr;33(4):860-6. (PMID: 15818117)
Curr Protoc Mouse Biol. 2012 Jun 01;2(2):167-75. (PMID: 26069010)
J Allergy Clin Immunol. 2014 Sep;134(3):509-20. (PMID: 25085341)
Am J Respir Crit Care Med. 2012 Aug 1;186(3):261-72. (PMID: 22679007)
Chest. 2012 Jan;141(1):210-221. (PMID: 22215829)
Am J Physiol. 1975 Nov;229(5):1365-70. (PMID: 1200155)
Mediators Inflamm. 2002 Feb;11(1):17-22. (PMID: 11926591)
Respir Res. 2006 Oct 11;7:125. (PMID: 17034639)
Inhal Toxicol. 2008 Feb;20(3):349-59. (PMID: 18300052)
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S. (PMID: 15194174)
Semin Immunol. 2002 Apr;14(2):123-32. (PMID: 11978084)
Br J Pharmacol. 2009 Oct;158(3):920-30. (PMID: 19788496)
Sci Rep. 2017 Mar 28;7(1):492. (PMID: 28352088)
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63. (PMID: 16376782)
Am J Pathol. 1977 Jan;86(1):183-276. (PMID: 64118)
Respir Res. 2009 Oct 13;10:95. (PMID: 19825167)
J Clin Invest. 2009 May;119(5):1298-311. (PMID: 19381013)
Clin J Am Soc Nephrol. 2006 Sep;1(5):1039-45. (PMID: 17699324)
Hypertension. 2000 Jan;35(1 Pt 2):324-8. (PMID: 10642319)
Eur J Clin Invest. 2014 Aug;44(8):697-706. (PMID: 24909545)
Am J Pathol. 1997 Sep;151(3):671-7. (PMID: 9284815)
Gastroenterology. 2014 Jun;146(7):1795-808.e12. (PMID: 24583060)
Cell Death Differ. 1999 Feb;6(2):99-104. (PMID: 10200555)
FASEB J. 2010 Dec;24(12):5024-32. (PMID: 20739612)
EMBO J. 1991 Jul;10(7):1635-41. (PMID: 1646711)
Lab Invest. 1963 Feb;12:131-55. (PMID: 13999512)
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H474-81. (PMID: 17369464)
Hypertension. 2001 Mar;37(3):845-50. (PMID: 11244006)
Nat Immunol. 2015 Jan;16(1):27-35. (PMID: 25521682)
J Mol Cell Cardiol. 2005 Aug;39(2):395-9. (PMID: 15907929)
FASEB J. 2019 Apr;33(4):5389-5398. (PMID: 30702925)
FASEB J. 2014 Aug;28(8):3494-505. (PMID: 24769669)
Regul Pept. 1987 Nov;19(3-4):233-42. (PMID: 3432603)
Clin Exp Allergy. 2004 Apr;34(4):567-75. (PMID: 15080809)
Mol Cell Biol. 2007 Apr;27(7):2499-511. (PMID: 17283064)
Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2417-23. (PMID: 16415071)
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H2069-75. (PMID: 20935149)
J Am Soc Nephrol. 2004 Aug;15(8):1993-2001. (PMID: 15284285)
Am J Respir Cell Mol Biol. 2004 Sep;31(3):302-8. (PMID: 15191914)
Physiol Genomics. 2001 Mar 08;5(2):89-97. (PMID: 11242593)
Am J Respir Cell Mol Biol. 2012 Nov;47(5):679-87. (PMID: 22842496)
J Mol Cell Cardiol. 2000 Jun;32(6):865-79. (PMID: 10888242)
FASEB J. 2017 Apr;31(4):1689-1697. (PMID: 28082350)
Peptides. 2002 Aug;23(8):1433-9. (PMID: 12182944)
Hum Pathol. 2004 Apr;35(4):488-95. (PMID: 15116331)
Nat Rev Cardiol. 2017 Oct;14(10):603-614. (PMID: 28593996)
Heart. 2012 Dec;98(24):1805-11. (PMID: 22760869)
Eur Heart J. 1992 Oct;13(10):1399-404. (PMID: 1396815)
Am J Physiol. 1992 Apr;262(4 Pt 1):C854-61. (PMID: 1566813)
Nature. 1995 Sep 21;377(6546):239-42. (PMID: 7545787)
Pol J Pharmacol. 2000 Sep-Oct;52(5):375-81. (PMID: 11334230)
المشرفين على المادة: 0 (Vascular Endothelial Growth Factor A)
0 (vascular endothelial growth factor A, mouse)
11000-17-2 (Vasopressins)
11128-99-7 (Angiotensin II)
1393-25-5 (Secretin)
31C4KY9ESH (Nitric Oxide)
4964P6T9RB (Aldosterone)
EC 3.4.23.15 (Renin)
تواريخ الأحداث: Date Created: 20191004 Date Completed: 20201109 Latest Revision: 20210110
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC6775067
DOI: 10.1038/s41598-019-50634-x
PMID: 31578376
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-019-50634-x